Ionizing radiation disrupts gut virome and bacteriome. Gut commensal viruses protect against intestinal damage and promote stem cell regeneration by inhibiting hyperactivation of RIG‐I and Notch signaling in stem cells. Fecal virome transplantation (FVT) from healthy donors can serve as a potential therapeutic intervention by enriching phages targeting
Xiaotong Zhao+17 more
wiley +1 more source
Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells [PDF]
Chaolun Li, GR Johnson
openalex +1 more source
Targeting eRNAs from TNFα‐associated super‐enhancers with ASOs effectively reduces TNFα expression and inflammatory responses in both mouse models and patient‐derived immune cells. The conserved nature of these regulatory regions between species highlights the potential of eRNA‐targeted approaches as a therapeutic strategy for chronic inflammatory ...
Minjeong Cho+12 more
wiley +1 more source
BCLAF1 restrains stress responses in hematopoietic stem cells to support expansion and repopulation. [PDF]
Crowley SJ+8 more
europepmc +1 more source
Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. [PDF]
Catherine M. Verfaillie+2 more
openalex +1 more source
This study discovered that the protein TEAD1a is crucial for neutrophil development. In zebrafish models, disrupting TEAD1a or its interaction with partner protein YAP1 caused severe neutrophil deficiency. TEAD1a functions during the early HSC stage, activates Notch1 signaling in the GMP stage, and triggers Spi1 and Cebpα to drive neutrophil terminal ...
Wang Yiqin+7 more
wiley +1 more source
Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. [PDF]
Sten Eirik W. Jacobsen+2 more
openalex +1 more source
Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]
Lim, Hong+3 more
core +1 more source
EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy
This review provides new perspectives on EGFR's activation, mutations, and their impact on tumor immunotherapy. It summarizes how EGFR is activated and the current EGFR targeting strategy, evaluates their clinical outcomes in combination with immunotherapy, highlighting differential responses in tumors with EGFR wild‐type and different mutants.
Yuanzhuo Gu+7 more
wiley +1 more source
Correction: The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies. [PDF]
Filipek-Gorzała J+3 more
europepmc +1 more source